Research programme: granulocyte colony-stimulating factor mimetics - AffymaxAlternative Names: G-CSF mimetics research programme - Affymax; Gematide; Granulocyte colony-stimulating factor mimetics research programme - Affymax
Latest Information Update: 27 Aug 2009
At a glance
- Originator Affymax
- Class Peptides
- Mechanism of Action Granulocyte colony stimulating factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Neutropenia
Most Recent Events
- 20 Feb 2004 Preclinical trials in Neutropenia in USA (unspecified route)